Dexcom (DXCM) Price to Earnings (2010 - 2026)

Dexcom (DXCM) has reported Price to Earnings for 17 consecutive years, with 102.04 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Earnings fell 46.41% year-over-year to 102.04 in Q2 2026; TTM through Jun 2026 was 25.43, a 57.56% decrease from a year earlier, with the FY2025 full-year figure at 30.54, down 42.09% from the prior year.
• Price to Earnings was 102.04 for Q2 2026 at Dexcom, down from 121.48 in the prior quarter.
• Over five years, Price to Earnings peaked at 926.57 in Q1 2023 and troughed at 92.47 in Q3 2025.
• A 5-year average of 314.29 and a median of 276.37 in 2025 frame the typical range for Price to Earnings.
• Across the five-year window, Price to Earnings jumped 104.85% in 2022 and plunged 60.84% in 2023, its largest moves.
• Over 5 years, Price to Earnings stood at 476.52 in 2022, then sank by 60.84% to 186.59 in 2023, then increased by 7.34% to 200.29 in 2024, then tumbled by 52.3% to 95.54 in 2025, then gained by 6.8% to 102.04 in 2026.
• The last three Price to Earnings figures came in at 102.04 (Q2 2026), 121.48 (Q1 2026), and 95.54 (Q4 2025), per Business Quant data.